23:49 , Jun 6, 2019 |  BC Extra  |  Company News

Management tracks: Grail taps Juno founder Bishop as CEO; plus Clovis, OncoCyte, Calico

Grail Inc. (Menlo Park, Calif.) hired Hans Bishop as CEO to succeed Jennifer Cook, who also stepped down from the cancer diagnostic company's board, citing family health reasons. Bishop, who has been on Grail’s board...
00:27 , Jul 21, 2017 |  BC Extra  |  Company News

Management tracks

Enzyme therapy company Aeglea BioTherapeutics Inc. (NASDAQ:AGLE) said President and CEO David Lowe resigned. Director and former interim CMO Anthony Quinn will be interim CEO while the company seeks Lowe's successor. Neurology and cardiovascular company...
00:22 , May 19, 2017 |  BC Week In Review  |  Financial News

Amyris raises $47M in first tranche of private placement

On May 11, biomanufacturing company Amyris Inc. (NASDAQ:AMRS) raised $47 million in the first tranche of a planned $95 million private placement from Royal DSM and other investors. Amyris Inc. (NASDAQ:AMRS), Emeryville, Calif. ...
23:07 , May 18, 2017 |  BC Innovations  |  Product R&D

Making cells compute

With efficiency in DNA engineering continuing to grow, and an increasing convergence between engineering and biology, synthetic biology -- in its “truest” form -- is coming within striking distance of translating preclinical proof of concept...
23:27 , Nov 10, 2016 |  BC Week In Review  |  Company News

Amyris deal

Amyris and an undisclosed company partnered to discover and develop a natural and natural-like compound library against an undisclosed target chosen by the partner. The companies will use Amyris’ uPharm technology, which identifies candidate natural...
07:00 , Oct 10, 2016 |  BC Week In Review  |  Financial News

Amyris financial update

Amyris Inc. (NASDAQ:AMRS), Emeryville, Calif.   Business: Biomanufacturing, Supply/Service   Date announced: 2016-09-30   Note: Amyris secured a five-year credit line of up to $25 million and an option for a $5 million strategic investment...
07:00 , Jun 13, 2016 |  BC Week In Review  |  Company News

Amyris, J&J deal

Amyris and Johnson & Johnson’s Janssen Biotech Inc. unit partnered to discover and develop a natural and natural-like compound library against an undisclosed target identified by Janssen. The companies will use Amyris’ uPharm platform technology,...
07:00 , Apr 18, 2016 |  BC Week In Review  |  Financial News

Amyris completes private placement

Amyris Inc. (NASDAQ:AMRS), Emeryville, Calif.   Business: Biomanufacturing, Supply/Service   Date completed: 2016-04-11   Type: Private placement   Raised: $5 million   Shares: 4.4 million   Price: $1.14   Shares after offering: 211.1 million  ...
07:00 , Apr 18, 2016 |  BC Week In Review  |  Financial News

Amyris financial update

Amyris Inc. (NASDAQ:AMRS), Emeryville, Calif.   Business: Biomanufacturing, Supply/Service   Date announced: 2016-03-08   Note: Amyris established an at-the-market program to sell up to $50 million of its shares. FBR Capital and MLV are the...
08:00 , Feb 22, 2016 |  BC Week In Review  |  Financial News

Amyris completes private placement of notes and warrants

Amyris Inc. (NASDAQ:AMRS), Emeryville, Calif.   Business: Biomanufacturing, Supply/Service   Date completed: 2016-02-19   Type: Private placement of notes and warrants   Raised: $20 million   Investors: Foris Ventures LLC; Naxyris S.A.; Biolding Investment S.A....